Revel Michel boosts NewcelX (NCEL) stake with share and warrant buys

Rhea-AI Filing Summary

NewcelX Ltd. CSO and Director Revel Michel reported open-market purchases of common shares and warrants. He bought 54,545 common shares at $2.75 per share and acquired 76,363 warrants, each giving the right to buy one common share at $3.025.

The filing states the combined purchase price for one common share and one accompanying warrant was $2.75. Following these transactions, Michel directly holds 957,530 common shares, alongside 76,363 warrants expiring on April 27, 2031.

Insider Trade Summary

Net Buyer: 130,908 shares ($149,999)

Net Buy 2 txns

Insider Revel Michel

Role CSO and Director

Bought 130,908 shs ($150K)

Type	Security	Shares	Price	Value
Purchase	Warrant (right to buy)	76,363	$0.00	--
Purchase	Common Shares, par value CHF 0.05 per share	54,545	$2.75	$150K

Holdings After Transaction: Warrant (right to buy) — 76,363 shares (Direct, null); Common Shares, par value CHF 0.05 per share — 957,530 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

Common shares purchased: 54,545 shares Share purchase price: $2.75/share Shares held after transaction: 957,530 shares +4 more

7 metrics

Common shares purchased 54,545 shares Open-market purchase on April 27, 2026 at $2.75 per share

Share purchase price $2.75/share Price for common shares in April 27, 2026 transaction

Shares held after transaction 957,530 shares Total NewcelX common shares directly owned after purchases

Warrants purchased 76,363 warrants Derivative securities acquired on April 27, 2026

Warrant exercise price $3.025/share Conversion or exercise price for each warrant into one common share

Warrant expiration date April 27, 2031 Expiration of warrants related to NewcelX common shares

Combined unit price $2.75 per share+warrant Price for one common share and one accompanying warrant

Key Terms

open-market purchase, Warrant (right to buy), par value CHF 0.05 per share, ten percent owner, +1 more

5 terms

open-market purchase financial

"transaction_action: "open-market purchase" for both transactions"

An open-market purchase is when an investor or a company buys shares on a public stock exchange at the going market price, rather than through a private deal. It matters to investors because these purchases change how many shares are available, can push the stock price up or signal confidence from large buyers, and often affect per-share metrics like earnings—think of it like someone buying lots of apples off a grocery shelf, reducing supply and potentially raising the price.

Warrant (right to buy) financial

"security_title: "Warrant (right to buy)""

par value CHF 0.05 per share financial

"security_title: "Common Shares, par value CHF 0.05 per share""

ten percent owner financial

"is_ten_percent_owner: 1 for reporting person"

conversion or exercise price financial

"conversion_or_exercise_price: "3.0250" for the warrant"

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Revel Michel

(Last) (First) (Middle)

C/O NEWCELX LTD.

HOHSTRASSE 1

(Street)

KLOTEN 8302

(City) (State) (Zip)

SWITZERLAND

(Country)

2. Issuer Name and Ticker or Trading Symbol
NewcelX Ltd. [ NCEL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
X	Officer (give title below)		Other (specify below)
	CSO and Director

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/27/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares, par value CHF 0.05 per share	04/27/2026		P		54,545	A	$2.75(1)	957,530	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Warrant (right to buy)	$3.025	04/27/2026		P		76,363		04/27/2026	04/27/2031	Common Shares, par value CHF 0.05 per share	76,363	(1)	76,363	D

Explanation of Responses:

1. The combined purchase price per one common share, par value CHF 0.05 per share ("Common Share"), and accompanying one warrant to purchase Common Share was $2.75.

	/s/ Michel Revel	04/29/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transactions did Revel Michel report for NewcelX (NCEL)?

Revel Michel reported buying NewcelX common shares and warrants. He purchased 54,545 common shares at $2.75 per share and 76,363 warrants linked to common shares, all in open-market transactions dated April 27, 2026, according to the Form 4 filing.

How many NewcelX (NCEL) shares does Revel Michel hold after this Form 4?

After the transactions, Revel Michel holds 957,530 NewcelX common shares directly. This total reflects his position following the April 27, 2026 open‑market purchase of 54,545 additional common shares at $2.75 per share as disclosed in the filing.

What are the terms of the NewcelX (NCEL) warrants bought by Revel Michel?

Michel acquired 76,363 NewcelX warrants exercisable at $3.025 per share. Each warrant relates to one common share and expires on April 27, 2031. The filing shows these derivative securities were bought on April 27, 2026 in an open‑market or private transaction.

What was the purchase price for NewcelX (NCEL) units bought by Revel Michel?

The combined purchase price per common share and accompanying warrant was $2.75. A footnote explains that each unit consisted of one common share with CHF 0.05 par value and one warrant to purchase a common share, together priced at $2.75.

Is Revel Michel considered a major shareholder of NewcelX (NCEL) in this filing?

Yes, the filing identifies Revel Michel as a ten percent owner of NewcelX. He is also listed as CSO and Director. The Form 4 indicates his roles as director, officer, and ten percent owner alongside the reported share and warrant purchases.